FULC Fulcrum Therapeutics, Inc.: institutional ownership and insider trading
160 funds reported holding $332M of Fulcrum Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $27.9M, with 28 new positions and 42 funds selling out; over the last 12 months insiders bought $1.49M and sold $59.0M on the open market.
FULC revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$26.2M, EPS -0.34
- Quarter ended Mar 31, 2026: revenue n/a, net income −$18.9M, EPS -0.25
- Quarter ended Dec 31, 2025: revenue n/a, net income −$20.3M, EPS -0.31
- Quarter ended Sep 30, 2025: revenue $0, net income −$19.6M, EPS -0.31
Famous investors holding FULC
- D. E. Shaw (D. E. Shaw & Co.): $11.1M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $6.03M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $10.8M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $5.44M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $2.97M, 0.0% of the portfolio
Largest institutional holders of FULC
- VANGUARD GROUP INC — $40.3M
- BlackRock, Inc. (BLK) — $32.3M
- EcoR1 Capital, LLC — $24.0M
- TANG CAPITAL MANAGEMENT LLC — $23.9M
- Nantahala Capital Management, LLC — $20.0M
- SUVRETTA CAPITAL MANAGEMENT, LLC — $13.5M
- D. E. Shaw & Co., Inc. — $11.1M
- CITADEL ADVISORS LLC — $10.8M
- VANGUARD CAPITAL MANAGEMENT LLC — $9.87M
- JANE STREET GROUP, LLC — $8.37M
Recent FULC insider trades
- Jul 17, 2026: Tang Kevin bought 167,616 shares ($595K)
- Jul 15, 2026: Tang Kevin bought 249,946 shares ($891K)
- Jun 26, 2026: Ezekowitz Alan sold 18,000 shares ($65.7K)
- Feb 2, 2026: Gould Robert J sold 15,000 shares ($161K)
5%+ owners
- TANG CAPITAL MANAGEMENT, LLC: 10.4% (Schedule 13G/A, filed Jul 15, 2026)
- EcoR1 Capital, LLC: 9.0% (Schedule 13G, filed Jun 25, 2026)
- Nantahala Capital Management, LLC: 8.2% (Schedule 13G, filed Aug 14, 2026)
- BlackRock, Inc.: 7.2% (Schedule 13G/A, filed Jul 28, 2026)
- BANK OF AMERICA CORP /DE/: 6.7% (Schedule 13G, filed Aug 3, 2026)
- BlackRock Portfolio Management LLC: 6.0% (Schedule 13G, filed Jul 17, 2026)
Who owns the most FULC stock?
The largest institutional holders of Fulcrum Therapeutics, Inc. in the latest 13F filings are VANGUARD GROUP INC ($40.3M), BlackRock, Inc. (BLK) ($32.3M), EcoR1 Capital, LLC ($24.0M).
Are insiders buying or selling FULC?
Over the last 12 months insiders bought $1.49M and sold $59.0M of Fulcrum Therapeutics, Inc. stock on the open market (SEC Form 4).
Which famous investors own FULC?
D. E. Shaw, Renaissance Technologies, Ken Griffin, Izzy Englander, Two Sigma.
Which ETFs hold FULC?
4 ETFs and mutual funds hold it among their top 100 positions, including XPH, PINK, PILL, PHPIX.